Heme oxygenase (HO) is believed to be a potent antioxidant enzyme in the nervous system; it degrades heme from heme-containing proteins, giving rise to carbon monoxide, iron, and biliverdin, which is rapidly reduced to bilirubin. The first identified isoform of the enzyme, HOI, is an inducible heat-shock protein expressed in high levels in peripheral organs and barely detectable under normal conditions in the brain, whereas H02 is constitutive and most highly concentrated in the brain. Interestingly, although H02 is constitutively expressed, its activity can be modulated by phosphorylation. We demonstrated that bilirubin, formed from H02, is neuroprotectant, as neurotoxicity is augmented in neuronal
Introduction
Heme oxygenase (HO) is the rate-limiting enzyme in heme degradation catalyzing cleavage of the heme ring to form ferrous iron, carbon monoxide (CO), and biliverdin. Biliverdin is rapidly cultures from mice with targeted deletion of H02 (H02-'-) and reversed by low concentrations of bilirubin. We now show that neural damage following middle cerebral artery ocdusion (MCAO) and reperfusion, a model of focal ischemia of vascular stroke, is substantially worsened in H02-' animals. By contrast, stroke damage is not significantly altered in HO -'-mice, despite their greater debility. Neural damage following intracranial injections of N-methyl-D-aspartate (NMDA) is also accentuated in H02-'-animals. These findings establish H02 as an endogenous neuroprotective system in the brain whose pharmacologic manipulation may have therapeutic relevance.
reduced by biliverdin reductase to bilirubin (BR) so that in intact tissues biliverdin rarely accumulates and the physiologic product of HO is primarily BR. Two principal forms of HO have been distinguished and molecularly cloned (1) . HO 1 is an inducible enzyme, also designated as heatshock protein-32, with new HOl protein synthesis elicited by multiple stimulants, especially those associated with red blood cell damage, such as heme and other porphyrins. HO1 is con-centrated in tissues such as the spleen and liver, which degrade heme from aged red blood cells. By contrast, H02 is constitutive and most concentrated in the brain and testes (2) , accounting for the great majority of HO activity in the brain, where HO2 is localized to selective neuronal populations (1, 3) .
Of the three products of HO, CO has been most extensively studied, especially as a potential neurotransmitter in the brain and autonomic nervous system (1, 3, 4) . Recent evidence implicates bilirubin as an antioxidant neuroprotectant (5, 6) . Neurotoxicity in brain cultures is exacerbated by HO inhibitors and in cultures from mice with targeted deletion of H02 (HO2-'-), whereas nanomolar concentrations of bilirubin are neuroprotective (5) . BR elicits substantial antioxidant effects and is probably the most abundant endogenous antioxidant in mammalian tissues (6) (7) (8) . Free radicals have been implicated as a causative agent in ischemic damage.
In the present study, we demonstrate that neural damage following middle cerebral artery occlusion (MCAO), a model of focal ischemia of vascular stroke, is substantially worsened in HO2 '-animals whereas stroke damage is not significantly affected in HO 1' mice. These findings implicate H02 as an endogenous neuroprotective system in the brain whose pharmacologic manipulation may have therapeutic relevance.
Materials and Methods

MCAO and Reperfusion
The study was conducted in accordance with National Institutes of Health (NIH) guidelines for the use of experimental animals, and protocols were approved by the Institutional Animal Care and Use Committee. Adult male mice (23-28 g) were obtained from Kenneth D. Poss and Susumu Tonegawa and have been described previously (4,9-11). The protocol used for MCAO was similar to one used before (12) , with a few modifications. Briefly, under halothane anesthesia, a 6-0 monofilament was inserted into the internal carotid artery through the stump of the external carotid artery and advanced 6 (13) .
Intrastriatal N-methyl-D-aspartate (NMDA) Injection Mice were anesthetized and unilateral stereotaxic microinjections (0.3 ,ul over 3-min period) were performed using 0.1 M phosphate-buffered saline (PBS) with or without NMDA (Sigma) following the protocol described by Ayata et al. (14) . Mice were killed by decapitation after 48 hr. Time-course and dose-response experiments were first performed to find the optimal conditions. Brains were frozen and 20-,um coronal cryostat sections were taken. The lesion area was measured by a computer-assisted system after Nissl staining.
Immunohistochemistry Animals were perfused with 370C Krebs/Henseleit buffer followed by 300 ml of 370C 4% paraformaldehyde (pH 7.4). Brains were postfixed for 2 hr and cryoprotected. Free-floating brain sections (40 ,um) were blocked with 4% normal goat serum for 1 hr in the presence of 0.2% Regional Cerebral Blood Flow (mVlOOgImin) (Fig. 1 bottom) . The distribution of tissue volume recruited into low-flow zones within the ischemic hemisphere was similar in WT and H02 ' groups. Mean blood flow in the nonischemic hemisphere was equivalent in WT (103 ± 4 ml/100 g/min; ±SE) and H02 / (104 5 ml/100 g/min) mice.
Ischemic Volume Is Increased in H02 / Animals
The volume of infarcted brain tissue following 1 hr of ischemia and 23 hr of reperfusion was 71 % greater in H02 / than in WT animals, whereas there was no difference in overall tissue volume between the two groups in the control hemisphere (Fig. 2) .
HO1 Is Induced after MCAO and Reperfusion
Since HO1 is induced following many types of stress, one might anticipate alterations following MCAO. There are reports of increased HO1 protein by immunohistochemical staining (16) (17) (18) (19) and HO 1 mRNA by Northern blot analysis (17, 19, 20) , but the exact cellular localization of the increase has been unclear. We observed a pronounced increase in HO 1 staining (mRNA and protein) that was highly concentrated at the border of infarcted tissue (Fig. 3) . The staining was localized to reactive microglia.
Ischemic Volume Is Similar in HO1 ' 1 and WT
Mice
The induction of HO1 after MCAO raises the possibility that it may mediate neurotoxic alterations. Accordingly, we evaluated ischemia in HO 1 -/ animals. We found no significant differences in infarct volume between WT and HOl / mice (Fig. 4) .
NMDA Neurotoxicity Is Augmented in H02 / Mice
We sought to ascertain which mechanisms of stroke damage might account for the augmented stroke damage in H02 ' animals. Neurotoxicity can be elicited by direct injections of NMDA into the brain. As reported previously (14) , we observed substantial neural damage following NMDA injections into the cerebral cortex (Fig. 5) . The extent of this damage was increased 3-to 4-fold in H02 ' mice.
Discussion
The substantial increase in MCAO-associated neural damage in H02-/-mice suggests that H02 normally performs a neuroprotective role in the brain. However, it is conceivable that loss of H02 causes nonspecific brain damage that worsens strokes. We think this is unlikely for the following reason. H02-/-mice have been extensively characterized in behavioral studies as showing no defects in an extensive range of sensory and motor tasks, including measures of olfaction, motivation, exploratory behavior, motor coordination, strength, and balance (11) , and long-term potentiation in brain slices is also normal (10) . The of NMDA into the brain and, as reported previously (14), we observed substantial neural damage following NMDA injections into the cerebral cortex (Fig. 3) . The extent of this damage was increased 3-to 4-fold in H02-'-mice. Thus, it appears that physiologic H02 activity is neuroprotective against glutamate excitatoxicity that involves NMDA receptor activation.
What might account for the neuroprotective action of H02? One of the enzyme's products, CO, is a putative neurotransmitter but it has not been directly linked to neuroprotective mechanisms (3, 4) . CO can dilate blood vessels, but there is no evidence that CO elaborated by H02 in neurons regulates vascular reactivity. Moreover, the reduction in perfusion during the entire ischemic period and the volume of tissue subjected to ischemic levels of blood flow were the same in H02-1-and WT mice. Thus the lack of hypothesized CO-mediated vasodilation during ischemia in H02-1-mice does not account for the greater infarction volume in these animals. By contrast, there is direct evidence for a neuroprotective role for BR. In hippocampal and cerebral cortical cultures, the neurotoxic effects of hydrogen peroxide (5), hemin and the Alzheimer's A31_42 peptide (22) (9) . Moreover, the physiologic egress of iron from fibroblasts is diminished in HO 1-/-preparations and augmented by transfection of HO 1 (23) . Whether H02 as well as HOl regulates iron efflux is unclear. Ferrous iron is highly toxic following its interaction with hydrogen peroxide in the Fenton reaction, so that a loss of H02 might lead to accentuated iron-mediated damage. It is noteworthy that brain levels of iron are similar in WT and the HO2'/-brains as observed by Prussian blue staining and quantified by atomic emission spectrometry (23) .
Our findings may have clinical relevance in cerebral ischemia. Since H02 deletion worsens stroke damage, activating the enzyme may be therapeutic. Drugs that augment H02 activity would be predicted to be neuroprotective. Recently, we showed that activation of heme oxygenase activity is cytoprotective for cultured neurons, fibroblasts, and human embryonic kidney 293 cells (5, 23) . HOI can be induced by a variety of agents, including several porphyrin derivatives (24) . However, HO1 activation is not likely to be neuroprotective, as in our experiments, stroke damage was not worse in HO I 1 -mice. Presumably, HO1 is not neuroprotective, because it is selectively localized to microglia, in contrast to H02, which is exclusively neuronal in the brain. The one known class of substances that activates H02 are phorbol esters that activate protein kinase C, which phosphorylates and activates H02 (5) . Phorbol esters are tumor promoters, which would preclude use for chronic therapy; however, acute treatment with such agents would be feasible. While most phorbol esters are lipophilic, water-soluble derivatives exist that could potentially be administered to stroke patients. Selectivity for protein kinase C activation might be feasible because of the numerous subtypes of the enzyme, some of which are specifically enriched in the brain (25) , and activation of H02 might occur to a greater extent with particular enzyme subtypes. Low doses of BR itself might also afford a therapeutic venue. BR is an effective antioxidant of peroxynitritemediated protein oxidation (26) and lipid peroxidation (6) . BR may be particularly important as a cytoprotector for tissues with relatively weak endogenous antioxidant defenses such as the myocardium (27) and the nervous system (28) . Interestingly, a decreased risk for coronary artery disease is associated with mildly elevated serum BR, with a protective effect comparable to that of HDL-cholesterol (8, 29) . There is evidence that BR associated with the physiologic jaundice of newborn babies is neuroprotective, since higher BR levels in premature infants are associated with a lower incidence of oxygen free-radicalmediated injury (7, 30, 31) and BR protects against retinopathy in premature babies (32) .
